International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products. The Company’s products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. International Stem Cell Corporation develops various cell types, including neural stem cells for the treatment of Parkinson’s disease and other central nervous system disorders, liver cells to treat various congenital and acquired liver diseases, and islet cells for the treatment of diabetes. It develops, manufactures, and markets skincare products and human cell culture products as well.